Raiffeisen Bank International’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.7M Buy
1,379,394
+1,308,133
+1,836% +$34.8M 0.56% 45
2025
Q4
$1.78M Sell
71,261
-3,989
-5% -$101K 0.02% 264
2025
Q3
$1.79M Buy
75,250
+22,478
+43% +$555K 0.02% 250
2025
Q2
$1.28M Sell
52,772
-1,059
-2% -$24.7K 0.02% 249
2025
Q1
$1.36M Buy
53,831
+14,937
+38% +$391K 0.02% 243
2024
Q4
$1.03M Buy
+38,894
New +$1.05M 0.02% 269

Other funds holding PFE

Raiffeisen Bank International's PFE Position: Q1 2026 in Review

Raiffeisen Bank International increased its Pfizer (PFE) stake by 1,836% in Q1 2026, buying an estimated $34.8M and bringing the position to 1,379,394 shares worth $38.7M. The position accounts for 0.56% of the portfolio, ranked #45.

Raiffeisen Bank International first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Raiffeisen Bank International held 1,379,394 shares of Pfizer worth $38.7M as of Q1 2026.
  • Raiffeisen Bank International bought 1,308,133 Pfizer shares in Q1 2026, an estimated $34.8M.
  • Pfizer made up 0.56% of Raiffeisen Bank International's portfolio in Q1 2026, its #45 holding.
  • Raiffeisen Bank International first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.